EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATIONS IN ADVANCED NON SMALL LUNG CANCER

  • Neringa Vagulienė
  • Marius Žemaitis
DOI: https://doi.org/10.37499/PIA.403
Keywords: non-small cell lung cancer, EFGR gene mutations, tyrosine kinase inhibitor

Abstract

Lung cancer is the major cause of cancer-related mortality in men and women worldwide. NSCLC comprise the majority of cases, and the prognosis of patients diagnosed with advanced NSCLC continues to be dismal. The development of personalized medicine with a focus on novel targeted therapies has supplanted the one-size-fitsall approach to the treatment of many cancers, including non-small cell lung cancer.

Author Biographies

Neringa Vagulienė

Department of Pulmonology and Immunology, Medical Academy, Lithuanian University of Health Sciences

Marius Žemaitis

Department of Pulmonology and Immunology, Medical Academy, Lithuanian University of Health Sciences

How to Cite
1.
Vagulienė N, Žemaitis M. EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATIONS IN ADVANCED NON SMALL LUNG CANCER [Internet]. PIA 2012 May;10(1):10-11.[cited 2024 Nov. 22 ] Available from: http://pia.pulmoalerg.lt/index.php/PIA/article/view/403
Issue
Vol 10 No 1 (2012): Pulmonology, Immunology and Allergology
Section
Pulmonology